{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:14:40Z","timestamp":1754162080136,"version":"3.41.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1023\/a:1026211620793","type":"journal-article","created":{"date-parts":[[2003,11,3]],"date-time":"2003-11-03T17:53:28Z","timestamp":1067882008000},"page":"473-480","source":"Crossref","is-referenced-by-count":7,"title":["A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Karl","family":"B\u00e9langer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Cairncross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan","family":"Gertler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Burdette-Radoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Souli\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Ludwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Wainman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5145877_CR1","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W","volume":"79","author":"SW Coons","year":"1997","unstructured":"Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79: 1381\u20131393, 1997","journal-title":"Cancer"},{"key":"5145877_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1005707203596","volume":"34","author":"C Daumas-Duport","year":"1997","unstructured":"Daumas-Duport C, Varlet P, Tucker M-L, Beuvon F, Cervera P, Chodkiewicz J-P: Oligodendrogliomas: part 1\u2013Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neurol Oncol 34: 37\u201359, 1997","journal-title":"J Neurol Oncol"},{"key":"5145877_CR3","first-page":"2091","volume-title":"Cancer Principles and Practice of Oncology","author":"V DeVita","year":"2001","unstructured":"DeVita V, Hellamn S, Rosenberg SA: Cancer Principles and Practice of Oncology, 6th edn. Lippincott William & Wilkins, Philadelphia, 2001, pp. 2091\u20132160, 213.","edition":"6th edn."},{"key":"5145877_CR4","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.1994.12.10.2013","volume":"12","author":"G Cairncross","year":"1994","unstructured":"Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C, Jr, Wainman N, Eisenhauer E for the National Cancer Institute of Canada Clinical Trials Group: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013\u20132021, 1994","journal-title":"J Clin Oncol"},{"key":"5145877_CR5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.1991.00530140123026","volume":"28","author":"JG Cairncross","year":"1991","unstructured":"Cairncross JG, Macdonald DR: Chemotherapy for oligodendroglioma. Arch Neurol 28: 225\u2013227, 1991","journal-title":"Arch Neurol"},{"key":"5145877_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1227\/00006123-199303000-00005","volume":"32","author":"AP Kyritsis","year":"1993","unstructured":"Kyritsis AP, Yung WKA, Bruner J, Gleason MJ, Levin VA: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32: 365\u2013371, 1993","journal-title":"Neurosurgery"},{"key":"5145877_CR7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3171\/jns.1992.76.5.0741","volume":"76","author":"J Glass","year":"1992","unstructured":"Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B: The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. Neurosurgery 76: 741\u2013745, 1992","journal-title":"Neurosurgery"},{"issue":"6","key":"5145877_CR8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00006123-199912000-00001","volume":"45","author":"D Fortin","year":"1999","unstructured":"Fortin D, Cairncross GJ, Hammond RR: Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 45(6): 1279\u20131291, 1999","journal-title":"Neurosurgery"},{"key":"5145877_CR9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0360-3016(97)00126-0","volume":"38","author":"B Donahue","year":"1997","unstructured":"Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Bander FL, Earle JD, Fischdach JA, Asbell SO, Gaspar LE, Markoe AM, Curran W: Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of radiation therapy oncology group 83\u201302. Int J Radiat Oncol Biol Phys 38: 911\u2013914, 1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5145877_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005072-199203000-00002","volume":"51","author":"EC Alvord Jr","year":"1992","unstructured":"Alvord EC, Jr: Is necrosis helpful in the grading of gliomas? Editorial opinion. J Neuropathol Exp Neurol 51: 127\u2013132, 1992","journal-title":"J Neuropathol Exp Neurol"},{"key":"5145877_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1005759220434","volume":"34","author":"C Daumas-Duport","year":"1997","unstructured":"Daumas-Duport C, Tucker M-L, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz JP: Oligodendrogliomas: part II\u2014a new grading system based on morphological and imaging criteria. J Neurol Oncol 34: 61\u201378, 1997","journal-title":"J Neurol Oncol"},{"key":"5145877_CR12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/1097-0142(19880601)61:11<2251::AID-CNCR2820611120>3.0.CO;2-D","volume":"61","author":"JM Kros","year":"1988","unstructured":"Kros JM, Troost D, van Eden CG, van der Werj JM, Uylings HBM: Oligodendroglioma: a comparison of two grading systems. Cancer 61: 2251\u20132259, 1988","journal-title":"Cancer"},{"key":"5145877_CR13","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.51.4.1140","volume":"51","author":"MJ van den Bent","year":"1998","unstructured":"van den Bent MJ, Kros JM, Heimans JJ, Pronk LC, van Groeningen CJ, Krouwer HGJ, Taphoorn MJB, Zonnenberg BA, Tijsser CC, Twijnstra A, Punt CJA, Boogerd W: Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Neurology 51: 1140\u20131145, 1998","journal-title":"Neurology"},{"key":"5145877_CR14","first-page":"1722","volume":"48","author":"YH Hsiang","year":"1988","unstructured":"Hsiang YH, Liu LF: Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48: 1722\u20131726, 1988","journal-title":"Cancer Res"},{"issue":"8","key":"5145877_CR15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1054\/bjoc.2001.1726","volume":"84","author":"M Gore","year":"2001","unstructured":"Gore M, Rustin G, Shuller J, Lane SR, Hearn S, Beckman RA, Ross G: Topotecan given as a 21\u2013day infusion in the treatment of advanced ovarian cancer. Br J Cancer 84(8): 1043\u20131046, 2001","journal-title":"Br J Cancer"},{"issue":"4","key":"5145877_CR16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2165\/00003495-199856040-00017","volume":"56","author":"RN Brogden","year":"1998","unstructured":"Brogden RN, Wiseman LR. Topotecan: a review of its potential in advanced ovarian cancer. Drugs 56(4): 709\u2013723, 1998","journal-title":"Drugs"},{"issue":"5","key":"5145877_CR17","first-page":"1062","volume":"8","author":"WP Mc Guire","year":"2000","unstructured":"Mc Guire WP, Blessing JA, Boolman MA, Lentz SS, Dunton CJ: Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 8(5): 1062\u20131067, 2000","journal-title":"J Clin Oncol"},{"issue":"8","key":"5145877_CR18","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.1996.14.8.2345","volume":"14","author":"JH Schiller","year":"1996","unstructured":"Schiller JH, Kim K, Hutson P, DeVore R, Glick J, Stewart J, Johnson D: Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial. J Clin Oncol 14(8): 2345\u20132352, 1996","journal-title":"J Clin Oncol"},{"issue":"5","key":"5145877_CR19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1200\/JCO.1997.15.5.2090","volume":"15","author":"A Ardizzoni","year":"1997","unstructured":"Ardizzoni A, Hansen H, Dombernowsky P, Gamucci T, Kaplan S, Postmus P, Giaccone G, Schaefer B, Wanders J, Verweij J: Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory an sensitive disease. J Clin Oncol 15(5): 2090\u20132096, 1997","journal-title":"J Clin Oncol"},{"issue":"10","key":"5145877_CR20","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1200\/JCO.1996.14.10.2785","volume":"14","author":"R Perez-Soler","year":"1996","unstructured":"Perez-Soler R, Glisson BS, Lee JS, Fossella FV, Murphy WK, Shin DM, Hong WK: Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan. J Clin Oncol 14(10): 2785\u20132790, 1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"5145877_CR21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1999.17.2.658","volume":"17","author":"J von Pawel","year":"1999","unstructured":"von Pawel J, Schiller JH, Shepherd FA, Fields SZ, Kleisbauer JP, Chrysson NG, Stewart DJ, Clark PI, Palmer MD, Depierre A, Carmichael J, Krebs JB, Ross G, et al: Topotecan versus cyclophosphamide, doxorubicin, an vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 17(2): 658\u2013667, 1999","journal-title":"J Clin Oncol"},{"key":"5145877_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00685936","volume":"34","author":"HS Friedman","year":"1994","unstructured":"Friedman HS, Houghton PJ, Schold SC: Activity of 9\u2013dimethylaminomethyl-10\u2013hydroxycamptothecin (topotecan) against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol 34: 171\u2013174, 1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"5145877_CR23","first-page":"725","volume":"53","author":"SM Blaney","year":"1993","unstructured":"Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG: Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res 53: 725\u2013727, 1993","journal-title":"Cancer Res"},{"key":"5145877_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00177437","volume":"30","author":"JP Lamond","year":"1996","unstructured":"Lamond JP, Mehta MP, Boothman DA: The potential of topoisomerase I inhibitors in the treatment of CNS malignancies. Report of a synergistic effect between topotecan and radiation. J Neurooncol 30: 1\u20136, 1996","journal-title":"J Neurooncol"},{"key":"5145877_CR25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"9","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC, Jr, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 9: 1277\u20131280, 1990","journal-title":"J Clin Oncol"},{"key":"5145877_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3171\/jns.1977.47.3.0329","volume":"47","author":"VA Levin","year":"1977","unstructured":"Levin VA, Crafts DS, Norman DM, Hoffer PB, Spire JP, Wilson CB: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47: 329\u2013335, 1977","journal-title":"J Neurosurg"},{"key":"5145877_CR27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1160::AID-CNCR21>3.0.CO;2-F","volume":"85","author":"HS Friedman","year":"1999","unstructured":"Friedman HS, Kerby T, Fields S, Zilisch JE, Graden D, McLendon RE, Houghton PJ, Arbuck S, Cokgor I, Friedman AH. Topotecan treatment of adults with primary malignant glioma. Cancer 85: 1160\u20131165, 1999.","journal-title":"Cancer"},{"key":"5145877_CR28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","volume":"18","author":"JS Smith","year":"2000","unstructured":"Smith JS, Perry A, Borrel TJ, Lee HK, O'Faalon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18: 636\u2013645, 2000","journal-title":"J Clin Oncol"},{"key":"5145877_CR29","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","volume":"90","author":"JG Cairncross","year":"1998","unstructured":"Cairncross JG, Ueki K, Zlatescu C. Specific genetic predictors of chemotherapeutic response and surival in patients with anaplastic oligodendroglioma. J Natl Cancer Inst 90: 1473\u20131479, 1998.","journal-title":"J Natl Cancer Inst"},{"key":"5145877_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3171\/jns.1996.85.4.0597","volume":"85","author":"K Peterson","year":"1996","unstructured":"Peterson K, Paliologos N, Forsyth P, Macdonald D, Cairncross JG: Salvage chemotherapy for oligodendrogliomas. J Neurosurg 85: 597\u2013601, 1996","journal-title":"J Neurosurg"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1026211620793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1026211620793\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1026211620793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:47:57Z","timestamp":1753818477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1026211620793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["5145877"],"URL":"https:\/\/doi.org\/10.1023\/a:1026211620793","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}